(Q36595218)

15 August 2017

1 reference

title

Improving outcomes in early prostate cancer: Part II--neoadjuvant treatment (English)

1 reference

15 August 2017

1 reference

Danish Mazhar

1

1 reference

15 August 2017

Sarah Ngan

series ordinal

2

1 reference

15 August 2017

Jonathan Waxman

series ordinal

3

1 reference

15 August 2017

publication date

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

98

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

731-734

1 reference

Neoadjuvant hormonal therapy before radical prostatectomy and risk of prostate specific antigen failure

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06370.X

10.1111/J.1464-410X.2006.06370.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference